21 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
18
Synthesis of quaternarya-amino acid-based arginase inhibitors via the Ugi reaction.
Institutes For Pharmaceutical Discovery
16
2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitors.
Institutes For Pharmaceutical Discovery
16
Discovery of (R)-2-amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginases I and II for treatment of myocardial reperfusion injury.
Institutes For Pharmaceutical Discovery
3
Binding ofa,a-disubstituted amino acids to arginase suggests new avenues for inhibitor design.
Drexel University
29
Opportunities and Challenges of Arginase Inhibitors in Cancer: A Medicinal Chemistry Perspective.
University of Turin
15
Discovery of (2R,4R)-4-((S)-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat Cancer.
AstraZeneca
60
Chemical similarities and differences among inhibitors of nitric oxide synthase, arginase and dimethylarginine dimethylaminohydrolase-1: Implications for the design of novel enzyme inhibitors modulating the nitric oxide pathway.
Flinders University
21
Recent advances in small molecule based cancer immunotherapy.
Southern Medical University
50
If small molecules immunotherapy comes, can the prime be far behind?
Zhejiang University
39
Targeting Metalloenzymes by Boron-Containing Metal-Binding Pharmacophores.
Sichuan University
28
Boronic acid-based arginase inhibitors in cancer immunotherapy.
Oncoarendi Therapeutics
6
Novel Arginase Inhibitors for Treating Cancer and Respiratory Inflammatory Diseases.
Smith, Gambrell & Russell
34
Purine derivatives and the use thereof as medicament
Boehringer Ingelheim International